Total Payments
$41,079
2024 Payments
$99.26
Companies
13
Transactions
70
Medicare Patients
3,324
Medicare Billing
$313,481
Payment Breakdown by Category
Research$39,890 (97.1%)
Food & Beverage$1,174 (2.9%)
Other$14.46 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $39,890 | 5 | 97.1% |
| Food and Beverage | $1,174 | 64 | 2.9% |
| Entertainment | $14.46 | 1 | 0.0% |
Payments by Type
Research
$39,890
5 transactions
General
$1,189
65 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $39,890 | 5 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $360.77 | 3 | $0 (2021) |
| ABBVIE INC. | $321.35 | 22 | $0 (2024) |
| Romark Laboratories, LC | $105.92 | 15 | $0 (2019) |
| PFIZER INC. | $99.67 | 8 | $0 (2021) |
| Gilead Sciences, Inc. | $92.25 | 4 | $0 (2024) |
| Shire North American Group Inc | $85.23 | 4 | $0 (2018) |
| Janssen Biotech, Inc. | $39.23 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $30.47 | 2 | $0 (2024) |
| Horizon Pharma plc | $16.68 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.26 | 5 | ABBVIE INC. ($48.02) |
| 2022 | $93.99 | 7 | ABBVIE INC. ($56.61) |
| 2021 | $249.67 | 10 | Janssen Scientific Affairs, LLC ($120.72) |
| 2020 | $197.03 | 5 | Janssen Scientific Affairs, LLC ($124.84) |
| 2019 | $39,941 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($39,890) |
| 2018 | $354.02 | 24 | Janssen Scientific Affairs, LLC ($115.21) |
| 2017 | $143.42 | 9 | AbbVie, Inc. ($72.49) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: VIROLOGY | ||||||
| 08/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.91 | General |
| 08/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: VIROLOGY | ||||||
| 12/06/2022 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Inflammation | ||||||
| 10/14/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: VIROLOGY | ||||||
| 05/24/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.19 | General |
| 04/13/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: VIROLOGY | ||||||
| 01/27/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/07/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: VIROLOGY | ||||||
| 12/14/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: VIROLOGY | ||||||
| 11/23/2021 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: INFLAMMATION | ||||||
| 09/09/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2021 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $120.72 | General |
| Category: Immunology | ||||||
| 08/05/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Immunology | ||||||
| 08/04/2021 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: INFLAMMATION | ||||||
| 07/07/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VIROLOGY | ||||||
| 06/23/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VIROLOGY | ||||||
| 05/18/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: VIROLOGY | ||||||
| 04/28/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Immunology | ||||||
| 12/02/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.27 | General |
| 10/28/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.88 | General |
| 09/17/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Triple Combination Therapy With Vedolizumab IV, Adalimumab SC, and Oral Methotrexate in Early Treatment of Subjects With Crohn's Disease Stratified at Higher Risk | Takeda Pharmaceuticals U.S.A., Inc. | $39,890 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 929 | 973 | $591,941 | $91,866 |
| 2022 | 12 | 713 | 745 | $371,564 | $66,428 |
| 2021 | 15 | 826 | 888 | $413,112 | $76,930 |
| 2020 | 16 | 856 | 929 | $431,855 | $78,257 |
Total Patients
3,324
Total Services
3,535
Medicare Billing
$313,481
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 132 | 133 | $129,128 | $25,519 | 19.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 220 | 220 | $188,305 | $21,977 | 11.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 45 | 45 | $29,749 | $7,688 | 25.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 122 | 123 | $84,216 | $6,970 | 8.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 48 | 51 | $31,447 | $4,924 | 15.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 75 | $14,006 | $4,360 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 108 | $15,941 | $3,970 | 24.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 61 | 61 | $15,912 | $3,808 | 23.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $33,622 | $3,651 | 10.9% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $18,177 | $2,960 | 16.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $15,089 | $2,717 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $4,051 | $1,061 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $4,074 | $959.21 | 23.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $5,216 | $905.08 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 12 | $3,009 | $396.88 | 13.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 139 | 140 | $114,840 | $15,931 | 13.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 69 | 69 | $64,534 | $13,326 | 20.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 47 | 47 | $32,050 | $8,017 | 25.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 100 | 100 | $61,726 | $6,432 | 10.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 104 | 116 | $17,122 | $4,350 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 62 | $11,546 | $3,350 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 36 | $12,221 | $3,228 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 53 | $12,631 | $3,003 | 23.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 34 | 34 | $8,836 | $2,503 | 28.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 22 | 22 | $13,037 | $2,444 | 18.8% |
About Dr. David Stokesberry, M.D
Dr. David Stokesberry, M.D is a Gastroenterology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427032234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Stokesberry, M.D has received a total of $41,079 in payments from pharmaceutical and medical device companies, with $99.26 received in 2024. These payments were reported across 70 transactions from 13 companies. The most common payment nature is "" ($39,890).
As a Medicare-enrolled provider, Stokesberry has provided services to 3,324 Medicare beneficiaries, totaling 3,535 services with total Medicare billing of $313,481. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oklahoma City, OK
- Active Since 12/05/2005
- Last Updated 07/11/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1427032234
Products in Payments
- Entyvio (Biological) $39,890
- STELARA (Biological) $400.00
- MAVYRET (Drug) $140.11
- Alinia Tablets 500mg 30 count bottle (Drug) $104.43
- Mavyret (Drug) $92.69
- XELJANZ (Drug) $49.97
- INFLECTRA (Biological) $49.70
- LIALDA (Drug) $45.41
- GATTEX (Drug) $39.82
- Viekira (Drug) $31.38
- DIFICID (Drug) $30.47
- RINVOQ (Biological) $17.73
- RAYOS (Drug) $16.68
- ZENPEP (Drug) $13.50
- AVSOLA (Biological) $12.05
- LINZESS (Drug) $11.85
- APRISO (Drug) $11.56
- CREON (Drug) $11.43
- Alinia (Drug) $1.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oklahoma City
George Salem, Md, MD
Gastroenterology — Payments: $872,730
Gastroenterology $872,730
Tauseef Ali, M.d, M.D
Gastroenterology — Payments: $616,367
Gastroenterology $616,367
Pooja Singhal
Gastroenterology — Payments: $178,683
Gastroenterology $178,683
Matthew Mcbride, Md, MD
Gastroenterology — Payments: $83,407
Gastroenterology $83,407
Dr. Trushar Patel, M.d, M.D
Gastroenterology — Payments: $81,054
Gastroenterology $81,054
Sanjay Sikka, M.d, M.D
Gastroenterology — Payments: $31,487
Gastroenterology $31,487